AbbVie
ABBV
#25
Rank
HK$2.870 T
Marketcap
HK$1,626
Share price
-0.40%
Change (1 day)
16.44%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : HK$1.024 Trillion

According to AbbVie's latest financial reports the company's total liabilities are HK$1.024 Trillion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$1.023 T5.39%
2023-12-31HK$970.89 B2.26%
2022-12-31HK$949.45 B-7.12%
2021-12-31HK$1.022 T-4.08%
2020-12-31HK$1.065 T40.65%
2019-12-31HK$757.68 B42.71%
2018-12-31HK$530.91 B3.45%
2017-12-31HK$513.22 B7.68%
2016-12-31HK$476.61 B25.23%
2015-12-31HK$380.59 B90.4%
2014-12-31HK$199.89 B4.34%
2013-12-31HK$191.57 B4.53%
2012-12-31HK$183.27 B210.94%
2011-12-31HK$58.94 B39.44%
2010-12-31HK$42.27 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
HK$970.89 B-5.23%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$592.45 B-42.17%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$500.94 B-51.10%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$668.21 B-34.78%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$308.98 B-69.84%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$88.09 B-91.40%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$452.40 B-55.84%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$490.99 B-52.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$8.77 B-99.14%๐Ÿ‡บ๐Ÿ‡ธ USA